State workers may strike Wednesday

A decision will be taken Monday or Tuesday, said Histadrut spokesman Eyal Melma.

October 16, 2006 09:21
strike sign 88

strike sign 88. (photo credit: )


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

State service workers may close down all public offices and authorities, including the National Insurance Institute, beginning Wednesday, the Histradrut said Sunday, but stressed that "for the moment there is no intention to do so." A decision will be taken Monday or Tuesday, said Histadrut spokesman Eyal Melma. The threat follows late September's announcement of a labor conflict by the Histadrut, in protest of government decisions and Finance Minister Avraham Hirchson's 2007 budget proposal, which the labor union said would lead to job losses. "They passed unilateral decisions. That is unacceptable; labor relations must be settled through negotiations," Melma said.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection